GlassScriptPhysician profile
Anthony Baxter Chin
NPI 1649315375
$1,971.85
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $175 · 2021: $304 · 2022: $358 · 2023: $293 · 2024: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascend Therapeutics US, LLC | $250.00 | 2020-2024 | |
| Mayne Pharma Commercial LLC | $177.39 | 2021-2024 | |
| Exeltis, USA INC. | $168.99 | 2019-2024 | Slynd |
| Therapeuticsmd, INC. | $168.50 | 2019-2022 | |
| Pfizer INC. | $157.97 | 2019-2022 | |
| Abbvie INC. | $153.33 | 2019-2021 | |
| Astellas Pharma US INC | $118.90 | 2019-2023 | Veozah |
| Vertical Pharmaceuticals, LLC | $115.91 | 2019 | |
| Amag Pharmaceuticals, INC. | $86.86 | 2019 | |
| Shield Therapeutics INC | $83.93 | 2023 | Accrufer |
| Exact Sciences Corporation | $62.80 | 2023-2024 | Cologuard Collection Kit |
| Myovant Sciences INC. | $61.70 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.32 | 2019 | |
| Avion Pharmaceuticals | $39.59 | 2022-2023 | Balcoltra |
| Coopersurgical, INC. | $33.54 | 2023 | Paragard T 380a |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $32.68 | 2019-2020 | |
| Ibsa Pharma INC. | $32.10 | 2024 | Licart, Tirosint |
| Biohaven Pharmaceutical Holding Company LTD. | $28.72 | 2022 | |
| Duchesnay USA Incorporated | $24.83 | 2019 | |
| Roche Diagnostics Corporation | $24.60 | 2019 | |
| Amgen INC. | $23.64 | 2019 | |
| Evofem Biosciences, INC. | $22.40 | 2021 | |
| Allergan, INC. | $19.93 | 2020 | |
| Medicem INC. | $19.29 | 2021 | |
| Sumitomo Pharma America, INC. | $17.93 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Chin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.